Immuno Oncology (I-O) Market [By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types (Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Head & Neck Cancer, Bladder Cancer, Classical Hodgkin’s Lymphoma and Merkel Cell Carcinoma); By Region]: Market